Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,681 | -5,962 | -4,241 | -1,978 | -728 |
| Depreciation Amortization | 122 | 796 | 673 | 447 | 205 |
| Accounts receivable | N/A | 48 | 48 | 48 | 19 |
| Other Working Capital | 630 | 1,344 | 987 | 800 | 347 |
| Other Operating Activity | 1,586 | 2,478 | 1,741 | 359 | -44 |
| Operating Cash Flow | $-343 | $-1,296 | $-792 | $-323 | $-200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3 | -3 | -3 | -3 |
| Investing Cash Flow | $N/A | $-3 | $-3 | $-3 | $-3 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 105 | 40 | 40 | 40 | N/A |
| Debt Issued | N/A | 210 | 210 | 210 | 210 |
| Common Stock Issued | 195 | 1,195 | 940 | N/A | N/A |
| Other Financing Activity | -4 | -256 | -153 | -34 | -16 |
| Financing Cash Flow | $296 | $1,189 | $1,037 | $216 | $194 |
| Beginning Cash Position | 53 | 163 | 163 | 163 | 163 |
| End Cash Position | 6 | 53 | 405 | 53 | 154 |
| Net Cash Flow | $-47 | $-110 | $242 | $-110 | $-9 |
| Free Cash Flow | |||||
| Operating Cash Flow | -343 | -1,296 | -792 | -323 | -200 |
| Capital Expenditure | N/A | -3 | -3 | -3 | -3 |
| Free Cash Flow | -343 | -1,299 | -795 | -325 | -203 |